Master in Pharmaceutical Biotechnology

Tuition fees are 3,505 USD per year.

Pharmaceutical Biotechnology is a master's degree taught in English at Alma Mater Studiorum - Università di Bologna, in Bologna, Italy, running two years for students holding a bachelor's degree in biotechnology, pharmacy, biology, or a related field. This field applies biological and biotechnological methods to the discovery, development, and production of medicines, covering subjects such as molecular biology, pharmacology, biochemistry, drug design, and the industrial processes used to manufacture biologic drugs such as therapeutic proteins, antibodies, and vaccines. Students typically study how biotechnological tools are used to identify drug targets, engineer biological molecules for therapeutic use, and test the safety and effectiveness of new treatments, alongside the regulatory frameworks that govern how pharmaceutical products move from laboratory research to clinical use and market approval. Coursework often includes laboratory training in techniques used across the pharmaceutical and biotech industry, as well as topics such as quality control, good manufacturing practice, and the economics of bringing a new drug to market. Because pharmaceutical biotechnology sits between basic science and applied industry, programs generally balance scientific depth with an understanding of how research findings translate into approved products. Graduates pursue careers in pharmaceutical and biotechnology companies, drug discovery and development roles, quality control and regulatory affairs, clinical research organizations, and academic or industrial research laboratories, and some continue into doctoral study in pharmaceutical sciences or biotechnology. Bologna, home to Alma Mater Studiorum - Università di Bologna, has established life-science and pharmacy departments relevant to this field, and the program is delivered in English to reach an international group of science graduates.